Glucose, Understanding, Integrated Digital Health, and Engagement (GUIDE) Study

Glucose, Understanding, Integrated Digital Health, and Engagement (GUIDE) Study

The purpose of this study is to evaluate whether an Integrated Digital Health (IDH) intervention with and without healthcare provider engagement, improves glycemic control and diabetes-related outcomes among adults with Type 2 diabetes. The study will also assess the feasibility of integrating this approach into routine primary care to support personalized, data-informed diabetes management.

Participants will complete a total of three study visits: a baseline visit (which includes consent, screening, and enrollment procedures), a 16-week follow-up visit, and a 32-week follow-up visit. Each study visit is expected to last approximately 30 minutes. In addition, participants will complete study surveys throughout the study period, which are expected to require approximately 30-40 minutes per survey. Depending on study group assignment, participants may also use study devices and mobile applications to track health behaviors and/or participate in telehealth visits with a healthcare provider. The frequency and duration of these activities will vary by study group.

Inclusion Criteria:

• diagnosis of T2D for at least one year
• recent 3 month-HbA1c, 8-11%
• ownership of a smartphone
• English or Spanish speaking.

Exclusion Criteria:

• pregnant
• not available or willing to use CGM or study device/platform
• serious medical conditions or active thought disorders (e.g., terminal cancer, schizophrenia)

In addition to the self-report of the HbA1c within the past 3 months, potential participants will be screened with a point-of-care (POC) HbA1c (A1CNow®+).